Disease
21 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
SEP 8, 2026 · INTERVENTIONAL STUDY
ClinicalTrials.gov
This is a pilot feasibility study registration with no results posted; it describes planned enrollment and outcome measures for a future prospective cohort study, not a completed trial.
AUG 26, 2026 · JOURNAL ARTICLE
Renal Failure
Large prospective cohort study with hard clinical endpoints (CVD and all-cause mortality), robust adjusted effect sizes, and confirmation across subgroups and sensitivity analyses, but observational design precludes practice-changing status.
AUG 26, 2026 · JOURNAL ARTICLE
Gut Microbes
A narrative review synthesizing evidence on sex differences in gut microbiome and cardiometabolic disease, providing an integrative summary rather than new empirical data or a definitive trial.
AUG 21, 2026 · JOURNAL ARTICLE
Gut Microbes
An exploratory methodological study developing a novel multi-omics framework in a single 10-week RCT; demonstrates proof-of-concept that fecal bile acids, lipids, and metabolites may complement traditional measures, but lacks independent validation and hard clinical outcomes.
AUG 20, 2026 · OBSERVATIONAL STUDY
ClinicalTrials.gov
This is a study registration for an observational study of a clinical decision-support tool that has not yet enrolled participants or reported results; it describes planned evaluation of clinician-reported actionability rather than hard clinical outcomes.
AUG 18, 2026 · OBSERVATIONAL STUDY
ClinicalTrials.gov
This is a registry record for a planned observational study with no results yet reported; Phase 2 is prospective and uncontrolled, examining surrogate cardiac endpoints in a small sample.
AUG 17, 2026 · INTERVENTIONAL STUDY
ClinicalTrials.gov
This is a clinical trial registry record with no reported results; the study is actively recruiting and outcomes have not yet been posted or analysed.
This is a recruiting interventional study with no results reported; it registers a mechanistic hypothesis about adiposomes in endothelial dysfunction, supported only by preliminary findings in cells, to be tested in 60 obese diabetic subjects over 4 years.